Brain, Behavior, & Immunity - Health (Dec 2020)

The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases

  • R. Dayne Mayfield,
  • Li Zhu,
  • Tyler A. Smith,
  • Gayatri R. Tiwari,
  • Haley O. Tucker

Journal volume & issue
Vol. 9
p. 100129

Abstract

Read online

SMYD1 and the skNAC isoform of the NAC transcription factor have both previously been characterized as transcription factors in hematopoiesis and cardiac/skeletal muscle. Here we report that comparative analysis of genes deregulated by SMYD1 or skNAC knockdown in differentiating C2C12 myoblasts identified transcripts characteristic of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s Diseases (AD, PD, and HD). This led us to determine whether SMYD1 and skNAC function together or independently within the brain. Based on meta-analyses and direct experimentation, we observed SMYD1 and skNAC expression within cortical striata of human brains, mouse brains and transgenic mouse models of these diseases. We observed some of these features in mouse myoblasts induced to differentiate into neurons. Finally, several defining features of Alzheimer’s pathology, including the brain-specific, axon-enriched microtubule-associated protein, Tau, are deregulated upon SMYD1 loss.

Keywords